2013•Journal of Clinical Pulmonary MedicineRequires access
Application value of procalcitonin in the diagnosis and treatment of patients with community-acquired pneumonia
Huan Zhang
Open publisher page 0 citations
Abstract
Objective To explore the application value of procalcitonin in the diagnosis,treatment and prognosis of patients with community-acquired pneumonia.Methods 111 patients with community-acquired pneumonia were divide into two groups by the level of procalcitonin.WBC DC,blood serum C-reactive protein,duration of hospital stay,total hospitalization expense,days of using antibiotics and the number of deaths were compared between the two groups.Results WBC DC,blood serum C-reactive protein,duration of hospital stay,total hospitalization expense,days of using antibiotics and the number of deaths were obviously higher in the increased procalcitonin group than in the normal group.Conclusion Procalcitonin has a high application value in the diagnosis and treatment of patients with community-acquired pneumonia,which can improve the effectiveness and efficiency and achieve the health-economics targets.